MGMilan Gupta

Milan Gupta

*This is an algorithmically generated author record based on publicly available information.

Milan Gupta has a total of 268 co-authors. Here are the top co-authors by number of shared publications:

  • Subodh Verma

    Division of Cardiovascular Surgery , St Michael's Hospital, University of Toronto , Toronto , Canada

    21 shared publications
  • Hwee Teoh

    Division of Cardiac Surgery (C.J.D., A.Z.H., A.K., A.Q., H.T., S.V.), St. Michael’s Hospital of Unity Health Toronto, Toronto, Ontario, Canada

    14 shared publications
  • Michelle Tsigoulis

    Canadian Cardiovascular Research Network , 3 Conestoga Drive, Suite 301, Brampton, ON , Canada L6Z 4N5

    10 shared publications
  • Adrian Quan

    Division of Cardiac Surgery (C.J.D., A.Z.H., A.K., A.Q., H.T., S.V.), St. Michael’s Hospital of Unity Health Toronto, Toronto, Ontario, Canada

    9 shared publications
  • Mahesh Kajil

    Canadian Cardiovascular Research Network , 3 Conestoga Drive, Suite 301, Brampton, ON , Canada L6Z 4N5

    8 shared publications
  • Narendra Singh

    Division of Cardiology, Medical College of Georgia at Augusta University, Augusta, Georgia, USA; Canadian Cardiovascular Research Network, Brampton, Ontario, Canada

    8 shared publications

Latest Publications

  • Open Access

    Awareness Among Primary Care Physicians in Canada of Guideline Recommendations for Lowering LDL-Cholesterol in High-Risk Patients

    by Zahra Taboun, Neil Naik, Vivien Brown, Peter Lin, Michelle Padarath, Robert A. Hegele, Milan Gupta


  • Open Access

    Physician Perspectives on the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction

    by Milan Gupta, Alan Bell, Michelle Padarath, Daniel Ngui, Justin Ezekowitz


  • Open Access

    Landscape of Lipid Management Following an Acute Coronary Syndrome Event: Survey of Canadian Specialists

    by Pishoy Gouda, Robert C. Welsh, Michelle Padarath, Jean C. Grégoire, Robert A. Hegele, Milan Gupta


  • Open Access

    A qualitative investigation of optimal perinatal health: the perspectives of south Asian grandmothers living in southern Ontario, Canada

    by Sujane Kandasamy, Rebecca Anglin, Leila Gaind, Dipika Desai, Gita Wahi, Milan Gupta, Sonia S. Anand

    Background: Perinatal health-seeking behaviours are influenced by various factors, including personal beliefs. South Asian women, who often live within a wide kinship system, can be influenced by the advice and guidance of their mothers and/or mothers-in-law. Methods: To explore the cultural health perceptions of South Asian grandmothers within this context, we used constructivist grounded theory to sample and interview 17 South Asian grandmothers who reside in Southern Ontario, Canada. Interviews were audio-recorded, transcribed verbatim, and coded/analyzed by three independent coders. Results: Many grandmothers emphasized that the preconception phase should focus on building healthy habits around nutrition, physical activity, and mental wellness; the pregnancy period should encompass an enriched environment (positive relationships, healthy routines, nutritional enhancement); and the postpartum phase should emphasize healing and restoration for both the mother and newborn (self-care, bonding, rebuilding healthy habits). Many of the grandmothers conceptualized these stages as a cyclical relationship where healing and restoration transitions gradually to re-establishing healthy habits before having a subsequent child. They also expressed responsibility in supporting their daughters and/or daughters-in-law with their family units and encouraging the transfer of perinatal health information. Conclusions: South Asian grandmothers are involved in supporting the family units of their children and involving them in perinatal health programming can be an effective way to translate health knowledge to South Asian women.


  • Open Access

    Ethnic and diet-related differences in the healthy infant microbiome

    by for the NutriGen Alliance, Jennifer C. Stearns, Michael A. Zulyniak, Russell J. de Souza, Natalie C. Campbell, Michelle Fontes, Mateen Shaikh, Malcolm R. Sears, Allan B. Becker, Piushkumar J. Mandhane, et al.

    The infant gut is rapidly colonized by microorganisms soon after birth, and the composition of the microbiota is dynamic in the first year of life. Although a stable microbiome may not be established until 1 to 3 years after birth, the infant gut microbiota appears to be an important predictor of health outcomes in later life. We obtained stool at one year of age from 173 white Caucasian and 182 South Asian infants from two Canadian birth cohorts to gain insight into how maternal and early infancy exposures influence the development of the gut microbiota. We investigated whether the infant gut microbiota differed by ethnicity (referring to groups of people who have certain racial, cultural, religious, or other traits in common) and by breastfeeding status, while accounting for variations in maternal and infant exposures (such as maternal antibiotic use, gestational diabetes, vegetarianism, infant milk diet, time of introduction of solid food, infant birth weight, and weight gain in the first year). We demonstrate that ethnicity and infant feeding practices independently influence the infant gut microbiome at 1 year, and that ethnic differences can be mapped to alpha diversity as well as a higher abundance of lactic acid bacteria in South Asians and a higher abundance of genera within the order Clostridiales in white Caucasians. The infant gut microbiome is influenced by ethnicity and breastfeeding in the first year of life. Ethnic differences in the gut microbiome may reflect maternal/infant dietary differences and whether these differences are associated with future cardiometabolic outcomes can only be determined after prospective follow-up.


  • Open Access

    Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

    by Subodh Verma, Shaun G. Goodman, Shamir R. Mehta, David A. Latter, Marc Ruel, Milan Gupta, Bobby Yanagawa, Mohammed Al-Omran, Nandini Gupta, Hwee Teoh, et al.

    We assessed the effectiveness of dual antiplatelet therapy (DAPT) post elective or urgent (i.e., post acute coronary syndrome [ACS]) coronary artery bypass graft surgery (CABG). We systematically searched MEDLINE, EMBASE, and the Cochrane Registry from inception to August 2015. Randomized controlled trials (RCTs) in adults undergoing CABG comparing either dual vs. single antiplatelet therapy or higher- vs. lower-intensity DAPT were identified. Nine RCTs (n = 4,887) with up to 1y follow-up were included. Five RCTs enrolled patients post-elective CABG (n = 986). Two multi-centre RCTs enrolled ACS patients who subsequently underwent CABG (n = 2,155). These 7 RCTs compared clopidogrel plus aspirin to aspirin alone. Two other multi-centre RCTs reported on ACS patients who subsequently underwent CABG comparing higher intensity DAPT with either ticagrelor (n = 1,261) or prasugrel (n = 485) plus aspirin to clopidogrel plus aspirin. Post-operative anti-platelet therapy was started when chest tube bleeding was no longer significant, typically within 24–48 h. There were no differences in all-cause mortality in clopidogrel plus aspirin vs. aspirin RCTs; conversely, all-cause mortality was significantly lower in ticagrelor and prasugrel vs. clopidogrel RCTs (risk ratio[RR] 0.49, 95 % confidence interval[CI] 0.33–0.71, p = 0.0002; 2 RCTs, n = 1695; I 2 = 0 %; interaction p < 0.01 compared to clopidogrel plus aspirin vs aspirin RCTs). There were no differences in myocardial infarctions, strokes, or composite outcomes. Overall, major bleeding was not significantly increased (RR 1.31, 95 % CI 0.81–2.10, p = 0.27; 7 RCTs, n = 4500). There was heterogeneity (I 2 = 42 %) due almost entirely to higher bleeding reported for the prasugrel RCT which included mainly CABG-related major bleeding (RR 3.15, 95 % CI 1.45–6.87, p = 0.004; 1 RCT, n = 437). Most RCT data for DAPT post CABG is derived from subgroups of ACS patients in DAPT RCTs requiring CABG who resume DAPT post-operatively. Limited RCT data with heterogeneous trial designs suggest that higher intensity (prasugrel or ticagrelor) but not lower intensity (clopidogrel) DAPT is associated with an approximate 50 % lower mortality in ACS patients who underwent CABG based on post-randomization subsets from single RCTs. Large prospective RCTs evaluating the use of DAPT post-CABG are warranted to provide more definitive guidance for clinicians.


  • Open Access

    Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice

    by Tamryn K. Law, Andrew T. Yan, Aanika Gupta, Mahesh Kajil, Michelle Tsigoulis, Narendra Singh, Subodh Verma, Milan Gupta

    For the primary prevention of cardiovascular disease, the Framingham Risk Score (FRS) is the most well-known risk prediction method. However, there are limited data regarding physicians' method of risk assessment and guideline adherence in clinical practice. In the PARADIGM (Primary cARe AuDIt of Global risk Management) study (March 2009–10), 105 primary care physicians across Canada prospectively collected data for 3015 patients (mean age 56 years, 59% men) without known cardiovascular disease, diabetes, or lipid-lowering medications at baseline. For each patient, the treating physician determined their cardiovascular risk, and reported the risk stratification method and subsequent treatment decisions. Kappa statistics assessed the agreement between the study-calculated FRS and the treating physician's reported risk assessment. The FRS was the most commonly reported risk assessment method, but was used in only 34.0% of patients. Regardless of the method used (even if the FRS was reportedly used), there was only fair agreement between the risk stratification as reported by the physician and the study-calculated FRS. Moreover, physicians recommended statin initiation in 92% of all patients that they identified as high risk; however, according to the study-calculated FRS, only 56% of the truly high-risk patients were recommended statin therapy. For the primary prevention of cardiovascular disease, these findings indicate a need to improve risk assessment and stratification, as misclassification directly contributes to suboptimal risk factor management in real-world clinical practice. Future studies should establish the optimal risk stratification method with quality improvement strategies for its subsequent implementation. http://clinicaltrials.gov/ct2/show/NCT00950703; NCT00950703.


  • HIGH RATE OF PROGRESSION TO DYSGLYCEMIA IN A SECONDARY PREVENTION COHORT OVER FIVE YEARS: FINDINGS FROM THE PRACTICE REGISTRY

    by Milan Gupta, Sadaf I. Sheikh, Sarika Gill-David, Sheriar Hirjikaka, Michelle Tsigoulis, Harpreet S. Bajaj